Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 02 08; 390(6):497-509.
View in:
PubMed
subject areas
Adult
Biopsy
Dose-Response Relationship, Drug
Double-Blind Method
Humans
Liver
Liver Cirrhosis
Non-alcoholic Fatty Liver Disease
Pyridazines
Thyroid Hormone Receptors beta
Treatment Outcome
Uracil
authors with profiles
Mary Rinella
Michael Charlton